Finance

Lists
Why is SKIN up 6,92%?
Dive Deeper
SKIN:NASDAQ
Skinhealth Systems Inc
11,56 US$
+6,92%
(+0,75) 1D
11,52 US$
-0,35% (-0,040)
After hours
Closed: 14 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKIN...
Open
11,09 US$
High
11,75 US$
Low
10,01 US$
Mkt. cap
1,51 მლრდ.
Avg. vol.
343,87 ათ.
Volume
56,09 ათ.
52-wk high
34,80 US$
52-wk low
10,01 US$
EPS
-0,22 US$
Beta
1,05
Shares outstanding
130,14 მლნ.
No. of employees
613
Open
11,09 US$
High
11,75 US$
Low
10,01 US$
Mkt. cap
1,51 მლრდ.
Avg. vol.
343,87 ათ.
Volume
56,09 ათ.
52-wk high
34,80 US$
52-wk low
10,01 US$
EPS
-0,22 US$
Beta
1,05
Shares outstanding
130,14 მლნ.
No. of employees
613
News stories
From web sources and news partners
TipRanks
TipRanks
·
14 საათის წინ
Beauty Health Executes Reverse Stock Split to Meet Nasdaq
Benzinga
Benzinga
·
18 საათის წინ
Full Transcript: Beauty Health Q2 2026 Earnings Call
About Skinhealth Systems Inc
CEOმარლა მალკოლმ ბეკი
Employees613
Founded1997
Headquartersლონგ-ბიჩი, კალიფორნია, ამერიკის შეერთებული შტატები
SectorPersonal care products
Analyst ratings
Based on 3 analysts giving stock ratings to SKIN in the past 3 months
Hold
Buy
0
Hold
3
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SKIN in the last 3 months.
Highest
Current 11,56 US$
1,00 US$ (-91,35%)
Average
0,97 US$ (-91,61%)
Lowest
0,90 US$ (-92,21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Oliver Chen
TD Cowen
Hold
Reiterated
0,90 US$
-92,2%
08/12/2026
Jonathan Block
Stifel Nicolaus
Hold
Maintained
1,00 US$
-91,3%
08/11/2026
Susan Anderson
Canaccord Genuity
Hold
Maintained
1,00 US$
-91,3%
08/06/2026
George Kelly
Roth MKM
Buy
Reiterated
2,00 US$
-82,7%
05/20/2026
Allen Gong
J.P. Morgan
Sell
Maintained
-
-
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
70,66 მლნ.
82,37 მლნ.
64,91 მლნ.
72,11 მლნ.
Cost of goods sold
25,02 მლნ.
29,33 მლნ.
20,47 მლნ.
22,78 მლნ.
Cost of revenue
25,02 მლნ.
29,33 მლნ.
20,47 მლნ.
22,78 მლნ.
Research and development expenses
1,70 მლნ.
1,68 მლნ.
1,10 მლნ.
1,41 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50,18 მლნ.
51,20 მლნ.
45,14 მლნ.
44,36 მლნ.
Operating expense
51,88 მლნ.
52,88 მლნ.
46,24 მლნ.
45,77 მლნ.
Total operating expenses
76,90 მლნ.
82,21 მლნ.
66,71 მლნ.
68,54 მლნ.
Operating income
-6,24 მლნ.
162,00 ათ.
-1,80 მლნ.
3,57 მლნ.
Other non operating income
811,00 ათ.
251,00 ათ.
25,00 ათ.
19,00 ათ.
EBT including unusual items
-10,64 მლნ.
-4,81 მლნ.
-6,81 მლნ.
-1,46 მლნ.
EBT excluding unusual items
-10,64 მლნ.
-4,82 მლნ.
-7,83 მლნ.
-1,46 მლნ.
Income tax expense
386,00 ათ.
3,30 მლნ.
-184,00 ათ.
1,21 მლნ.
Effective tax rate
-3,63%
-68,55%
2,70%
-82,68%
Other operating expenses
-
-
-
-
Net income
-11,03 მლნ.
-8,10 მლნ.
-6,63 მლნ.
-2,67 მლნ.
Net profit margin
-15,61%
-9,84%
-10,21%
-3,70%
Earnings per share
0,57
-
0,62
1,57
Interest and investment income
1,26 მლნ.
1,51 მლნ.
1,48 მლნ.
1,29 მლნ.
Interest expense
-6,31 მლნ.
-6,37 მლნ.
-6,35 მლნ.
-6,30 მლნ.
Net interest expenses
-5,06 მლნ.
-4,86 მლნ.
-4,86 მლნ.
-5,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
2,19 მლნ.
5,51 მლნ.
3,54 მლნ.
8,84 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები